InsidersTradesSigma
Follow the 엘앤씨바이오 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 엘앤씨바이오 has published 74 reports. Market capitalisation: €1,182.7bn. The latest transaction was filed on 30 April 2026 (Sale). Among the most active insiders: 이환철. All data is openly available.
74
Insider Decl.
n/a
Thresholds
€111,132
45 ops.
Buy Volume
n/a
14 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,552 of 29,056 companies
32.5
score / 100
Value26
Quality39
FCF yld-0.4%
Earn yld-11%
EV/EBITDA·
ROE-53%
Gross mgn53%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 April 2026
Declarations74 total
1,253,131 sharesKRXDART:20250710000520
501,254 sharesKRXDART:20250610000363
25 of 74 declarations
Acerca de 엘앤씨바이오
엘앤씨바이오 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se especializa en el desarrollo de productos biofarmacéuticos.